pancreas semaglutide GLP-1s May Lower Risk of Acute Pancreatitis in Patients with T2D, Obesity What is Semaglutide? The Science

Plant Physiol Biochem 38(78):531540

Some patients worry: "If I lose weight and my BMI drops below 30, will they stop covering Wegovy?" Generally, insurers don't discontinue coverage just because you've lost weight that would defeat the purpose

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

The most commonly reported side effects in clinical trials were injection site reactions (like redness and itching), joint pain (arthralgia), and fluid retention

A meta-analysis suggests that, compared with patient self-monitoring, continuous glucose monitoring is associated with short-term A1C lowering of approximately 0.26%

(e.g., from 2.4mg to 1.7mg)